Opinion|Videos|October 16, 2024

Faricimab for DME: Durability and Patient Outcomes

Key Takeaways

Dante J Pieramici, MD, shifts the conversation to diabetic macular edema (DME) and the promising drying and anatomical results from an open-label long-term extension trial.

Latest CME